Terumo (OTCMKTS:TRUMY) Shares Gap Down – What’s Next?

Terumo Corp. (OTCMKTS:TRUMY)’s stock price gapped down before the market opened on Friday. The stock had previously closed at $14.72, but opened at $14.21. Terumo shares last traded at $14.2427, with a volume of 1,217 shares changing hands.

Analyst Ratings Changes

Separately, Nomura upgraded shares of Terumo from a “hold” rating to a “strong-buy” rating in a report on Thursday, July 30th. One analyst has rated the stock with a Strong Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat, Terumo currently has an average rating of “Buy”.

Terumo Stock Performance

The stock’s 50-day moving average price is $15.13 and its 200-day moving average price is $14.15. The company has a market cap of $20.96 billion, a P/E ratio of 20.01 and a beta of 0.77. The company has a debt-to-equity ratio of 0.13, a current ratio of 2.19 and a quick ratio of 1.37.

Terumo (OTCMKTS:TRUMY) last released its earnings results on Friday, August 7th. The company reported $0.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.17 by $0.13. The company had revenue of $1.97 billion for the quarter, compared to analyst estimates of $1.84 billion. Terumo had a return on equity of 10.44% and a net margin of 13.83%. Equities analysts anticipate that Terumo Corp. will post 0.86 EPS for the current year.

Terumo Company Profile

Terumo Corporation is a Japan-based medical technology company that develops, manufactures and sells products used in hospitals, clinics and other healthcare settings. Founded in 1921 by a group of Japanese medical doctors, the company initially produced clinical thermometers and has since expanded into a global provider of medical devices and related services.

Terumo’s principal businesses include cardiac and vascular products, blood and cell technologies, and general hospital solutions.